NL
DE
An EFRO grant (European Fund for Regional Development) of € 948,808 was assigned to the researchgroup of the DIABIP project led by Kirsten Kluivers, urogynaecologist of the Radboudumc, and part of the theme Reconstructive and regenerative medicine.
DIABIP, diagnosis and treatment for urinary incontinence and pelvic organ prolapse, is a research collaboration project between the gynaecology (Kirsten Kluivers, Alejandra Ruiz-Zapata and Wilke Post), urology (John Heesakkers, Egbert Oosterwijk and Dick Janssen) and genetics department (Geert Poelmans and Marieke Coenen) of the Radboudumc and the two SME's DrugtargetID and Nimagen.
Urinary incontinence and pelvic organ prolapse are the most common pelvic floor disorders that affect 24-46% of women world-wide. These common multifactorial conditions are poorly understood, understudied and have suboptimal treatments. With this grant the research group will investigate genetic and biological processes involved in the development pelvic floor disorders and select possible repurposed drugs in the treatment of these conditions.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Turbo Grants for four medical-technical research projects
19 October 2021 Four TURBO grants were recently awarded to new technical-medical research proposals. The grants are part of the TURBO program, a collaboration between the University of Twente (TechMed Centre) and the Radboudumc. read more
Epigenetics: Immunization is passed on to offspring Mice transmit adaptations to infections to next generations
19 October 2021 Does an infection affect the immunization of subsequent generations? It does, according to research now published in Nature Immunology. read more
Research into treatment for bladder pain syndrome will now be reimbursed
4 August 2021 Bladder pain syndrome, also called interstitial cystitis, is a chronic benign condition of the urinary bladder read more
Plugging the gap ZonMw/Health Holland grant
3 March 2020 RIMLS en RIHS researchers Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt and Janneke Grutters have been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM). read more
Regenerative medicine could treat fecal incontinence, in the future
15 November 2018 Wiep de Lingy and Alejandra Ruiz-Zapata, theme Reconstructive and regenerative medicine, systematically reviewed preclinical and clinical studies looking into regenerative medicine strategies to treat fecal incontinence in a recent publication in the American Journal of Obstetrics and Gynecology. read more
